Allogene Therapeutics Inc (ALLO)
2.11
+0.06
(+2.93%)
USD |
NASDAQ |
Nov 21, 16:00
2.11
0.00 (0.00%)
After-Hours: 20:00
Allogene Therapeutics Revenue (Quarterly)
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 0.022M |
December 31, 2023 | 0.021M |
September 30, 2023 | 0.022M |
June 30, 2023 | 0.022M |
March 31, 2023 | 0.03M |
December 31, 2022 | -0.04M |
September 30, 2022 | 0.049M |
Date | Value |
---|---|
June 30, 2022 | 0.086M |
March 31, 2022 | 0.061M |
December 31, 2021 | 75.65M |
September 30, 2021 | 0.049M |
June 30, 2021 | 0.044M |
March 31, 2021 | 38.34M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
-0.04M
Minimum
Dec 2022
75.65M
Maximum
Dec 2021
8.797M
Average
0.044M
Median
Jun 2021
Revenue (Quarterly) Benchmarks
ANI Pharmaceuticals Inc | 148.33M |
AIM ImmunoTech Inc | 0.035M |
Perspective Therapeutics Inc | -- |
Protalix BioTherapeutics Inc | 17.96M |
Armata Pharmaceuticals Inc | -- |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | -66.29M |
Total Expenses (Quarterly) | 61.05M |
EPS Diluted (Quarterly) | -0.32 |
Enterprise Value | 150.84M |
Earnings Yield | -73.93% |
Normalized Earnings Yield | -81.58 |